en - fr
Facebook Twitter Linkedin Youtube

Press releases and announcements

 
> News > Press releases and announcements > Medsquare signs a partnership with Virtual Phantoms to add a new module: calculation of the organ dose
 

Medsquare signs a partnership with Virtual Phantoms to add a new module: calculation of the organ dose

 

Written by : Karen Frangie - 03/03/17 - In Press releases and announcements

 
Medsquare is proud to announce the integration of the organ dose module VirtualDose™CT into its DACS Radiation Dose Monitor (RDM) solution. Developed in partnership with Virtual Phantoms, Inc., this new module will be added to RDM’s existing features and will be presented for the first time at the European Congress of Radiology (ECR).

The features of the organ dose module are the following:

• Monte Carlo algorithm calculation of mean doses delivered to organs by type of activity using existing dose data (DLP, CTDI, etc.)
• Estimation of the dose received by the fetus from the different stages of gestation of the pregnant woman
• Several parameters are considered: weight, height, age, pregnancy stages of the pregnant woman, etc.
• Calculation in accordance with ICRP- 60 and ICRP-103 recommendations
“With the calculation of the organ dose, Medsquare is opening a new perspective on patient radiation safety. This agreement − the fruit of over several months of exchanges between the two companies − continues the process of reducing and optimizing the dose delivered to the patient,” said Dominique Gabriel, CEO Medsquare.

About Virtual Phantoms Inc.

Virtual Phantoms, Inc. was founded in 2009 by faculty members from Rensselaer Polytechnic Institute, in collaboration with the University of Florida, with an exclusive license of the “Virtual Patient” technologies developed from nearly 20 years of research at RPI and UF in the field of nuclear and radiological engineering.

Combining a large collection of anatomically accurate models of patients of various ages and sizes and sophisticated “Monte Carlo” simulation methods originally developed for nuclear weapons research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling of ionizing radiation, radiation safety, and medical/occupational radiation dosimetry.

For more information about Virtual Phantoms or VirtualDose™CT:

Website: www.virtualphantoms.com
Contact: Peter Caracappa, VPI Chief Technology Officer
E. peter.caracappa@virtualphantoms.com
M. +1 518-421 6931

 
 
Share the post : Facebook Twitter Linkedin